Decentralized Trials
43 videos · last 6 months shuffled daily, then older videos newest first
▶
1:29 The Benefits of Community-Based Clinical Research
Tonya Edison, Executive Director of Clinical Central Services & Innovation at Eli Lilly and Company, explains how bringing clinical trials into local communities reduces logistical burdens and widens access, for The Hill.
▶
34:01 Protocol Design Before Trial Software
Harsha Rajasimha, founder and CEO of Jeeva Clinical Trials, discusses why protocol design must come before trial software and how fragmented systems burden site coordinators, on the Don't Sweat the Ledger podcast.
▶
56:03 Remote Trials and Digital Endpoints in Underserved Indications
Meri Beckwith of Lindus, Simon Bock of Tiefenbacher Group and ReMEdi trial investigator Beata Godlewska discuss how the fully remote Phase IIa ME/CFS trial captured 22 endpoints per patient and what remote designs offer underserved indications.
▶
58:24 Analytical Mass Spectrometry Workflow for VAMS and Its Applications in Cardiology and Beyond
Jenny Van Eyk, Professor of Cardiology at Cedars-Sinai, on a mass spectrometry proteomic workflow for volumetric absorptive microsampling, moderated by Neil Spooner of the Patient Centric Sampling Interest Group.
▶
29:59 Jean-Sébastien Gosuin on Patient-Centred Digital Research
Jean-Sébastien Gosuin, founder of Curewiki, discusses how digital innovation and patient-led insights can address barriers to clinical trial participation, including distance from study sites, for mdgroup.
▶
54:41 CTN-Lite Survey Results: Patient & Caregiver Priorities for ME/CFS Decentralized Trials
Dr. Danielle Meadows on the CTN-Lite survey of 1,258 ME/CFS patients and caregivers, which ranked the symptoms, biological systems and outcome measures that decentralized trials should prioritise.
▶
1:01:08 Digital Clinical Measures in Oncology Research
Jeremy Wyatt, CEO of ActiGraph, and Kate Lyden, chief science officer of VivoSense, join an Xtalks panel on why oncology has been slow to adopt digital clinical measures and how wearables are being used.
▶
20:06 Walgreens Enters the Clinical Trials Business
A video takes a deep dive into the Walgreens clinical trial model and what Walgreen's thinks makes it different from other models.
▶
45:20 PROGRESS: Lessons From a Fully Remote Digital Study
Ed Ramos and Katie Baca-Motes discuss PROGRESS, a fully remote metabolic health study at the Scripps Research Digital Trials Center: integrating glucose, wearable, nutrition, biospecimen and EHR data, and using incentives and data return for engagement.
▶
46:58 Decentralized Clinical Trials Forum, Clinical Trials BC
Speakers from LifeLabs, UBC, AbCellera and RealTime discuss home services, digital health, CRO operations and eConsent in decentralized trials at the Clinical Trials BC Symposium 2023.
▶
15:30 Data Privacy in Decentralized Clinical Trials
CISCRP interviews a clinical trial participant and two employees of Curebase about data privacy in decentralized clinical trials and also patient access to clinical trial results following the end of the clinical trial.
▶
25:37 Fully Remote eCOA in Decentralized Trials
A Kayentis webinar from September 2022 on the new risks decentralized trials bring for eCOA, reducing eCOA data quality risks and reconciliation, and using technology to support eCOA compliance monitoring.
▶
1:25 Walgreens Building the Future of Clinical Trials
Walgreens wants to expand access to clinical trials beyond the 5% of the US population who participates in clinical trials, 75% of whom are Caucasian and has 9000 stores across the US to bring trials to a more diverse patient population using their Pharmacy care teams.
▶
18:53 Opportunities and Pitfalls for Decentralized Clinical Trials
Dr Paul Wicks of Wicks Digital Health on the opportunities and pitfalls of decentralized clinical trials, at the 8th HRB-TMRN Symposium.
▶
14:22 Rethinking Decentralization in Direct-to-Patient Studies
Aaron Berger, SVP and Head of Evidence Development Solutions at UBC, discusses how direct-to-patient study designs have evolved and how they are reshaping clinical research, for HealthEconomics.Com.
▶
59:33 Decentralized Studies for Cancer Screening Diagnostics
Elligo Health Research speakers discuss hybrid and decentralized strategies for clinical performance studies of liquid biopsy cancer screening diagnostics, including recruitment, specimen logistics and data integrity.
▶
1:00:29 Ethics of Decentralized Clinical Trials: Effy Vayena
Effy Vayena, PhD, describes the ethical issues decentralized clinical trials raise for participant safety and rights, scientific validity and ethics oversight, and suggests how they could be addressed, in a Berman Institute research ethics talk.
▶
50:08 Overcoming the Challenges of Decentralised Clinical Trials
Paul Wicks PhD., Liam Eves, and special guest Craig Lipset discuss the most pressing challenges facing decentralised clinical trials today.
▶
57:11 EvidentIQ Webinar: eCOA and EDC for Hybrid Trials
EvidentIQ explains how EDC and eCOA can be combined to collect trial data in hybrid studies, keeping study control with site staff while eCOA and ePRO tools meet patients wherever they are, and how both can underpin a decentralized trial.
▶
2:24 Reaching Diverse Patients Using Social Media
Eli Lilly developed a mobile lab to bring trials to increase diversity and most people now learn about trials through social media in this video looking at diversity and how the lab is now being used to bring decentralized clinical trials to underrepresented populations.
▶
31:10 The Remote Collection of Multi-Modal Data for Decentralized Clinical Trials
Aparito's Dr Clare Matthews and Sandra Komarzynski present remote multi-modal data collection in decentralised trials, including the DMDHome app built with Duchenne UK to assess Duchenne patients at home through filmed tasks and questionnaires.
▶
56:00 Digital, Decentralized Studies: Dr. Edward Ramos
Edward Ramos gives a keynote on opportunities for clinical research using a digital, decentralized study approach, followed by audience questions, at a MassAITC and a2 Collective event.
▶
1:01:54 Navigating the Regulatory Landscape in Clinical Trials in 2024
Marc Wartenberger, Director of Corporate QA and Compliance at CRIO, reviews the regulations and guidance from 2023 that affect clinical trials, including Part 11, decentralized trials and patient diversity, and what to expect in 2024.
▶
45:05 Blood Microsampling in Clinical Trials
Trajan and IQVIA discuss how blood microsampling fits decentralized and hybrid trials, covering home self-collection, bioanalytical considerations, kit logistics and training for sites and patients.